Detalhe da pesquisa
1.
Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer.
Gynecol Oncol
; 184: 51-56, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281412
2.
The role of niraparib for the treatment of ovarian cancer.
Future Oncol
; 14(25): 2565-2577, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856239
3.
Perceived Barriers to Goals of Care Discussions With Patients With Advanced Cancer and Their Families in the Ambulatory Setting: A Multicenter Survey of Oncologists.
J Palliat Care
; 33(3): 125-142, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29607704
4.
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Breast Cancer Res
; 19(1): 2, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057046
5.
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis.
Gynecol Oncol
; 147(1): 158-166, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28689667
6.
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Gynecol Oncol
; 145(3): 584-594, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222899
7.
Bone Modifier Use as Adjuvant Therapy for Early Breast Cancer.
Curr Oncol Rep
; 19(3): 15, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251493
8.
Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer.
J Cancer Policy
; 36: 100421, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030536
9.
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
Cancers (Basel)
; 15(6)2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980708
10.
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma.
Nat Commun
; 14(1): 1452, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922497
11.
Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline.
Curr Oncol
; 29(1): 231-242, 2022 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35049696
12.
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report.
JCO Precis Oncol
; 6: e2200355, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240472
13.
The needs of gynecological cancer survivors at the end of primary treatment: A scoping review and proposed model to guide clinical discussions.
Patient Educ Couns
; 105(7): 1761-1782, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865888
14.
Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer.
JAMA Oncol
; 7(9): e212140, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236387
15.
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review.
Crit Rev Oncol Hematol
; 162: 103324, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862245
16.
Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer: A secondary analysis of MA.27, MA.17 and MA.17R.
Eur J Cancer
; 149: 117-127, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853037
17.
The Voices of Young Women with Breast Cancer: Providing Support and Information for Improved Fertility Preservation Discussions.
J Adolesc Young Adult Oncol
; 8(5): 547-553, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158039
18.
Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials.
Eur J Cancer
; 77: 40-47, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28355581
19.
Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis.
Cancer Treat Rev
; 53: 120-127, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104567
20.
The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.
Mol Diagn Ther
; 20(4): 307-13, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27235162